Updated Policies on Autism Spectrum Disorder and Developmental Surveillance Screening - December 2019
The Council on Children with Disabilities (COCWD) and the Section on Developmental and Behavioral Pediatrics (SODBP) authored an updated clinical report (Identification, Evaluation, and Management of Children with Autism Spectrum Disorder) on autism spectrum disorder (ASD) recommending the following:
1. Conduct developmental and behavioral surveillance during all well visits with children, developmental screening at the 9-, 18-, and 30-month visits, and standardized screening of patients for ASD at 18 and 24 months of age.
2. Help ensure that children with ASD are provided with evidence-based services to address social, academic and behavioral needs at home and school, with access to appropriate pediatric and mental health care, respite services and leisure activities.
3. Engage with families and youth to plan a transition to the adult system of medical and behavioral care.
4. Inform patients and families about the evidence for interventions, refer families for possible participation in clinical research and refer families to support organizations.
Read the Full Report here
Executive Summary here
The second report (Promoting Optimal Development: Identifying Infants and Young Children with Developmental Disorders Through Developmental Surveillance and Screening)recommends the following :
1. Physicians should perform developmental surveillance at every well child visit from early childhood through adolescence.
2. Physicians should refer a child to early intervention or preschool special education as well as for complete developmental and medical evaluations when the child is determined to be at risk for a developmental disorder based on screening or surveillance.
3. Standardized developmental screenings should be conducted at the 9-, 18-, and 30-month well-child visits. In addition, physicians should administer a screening for ASD during the 18- and 24-month health supervision visits.
4. Medical providers should identify and address barriers to screening in the medical home -- such as payment, professional education and office workflow -- to achieve universal screening of all children during early childhood.
5. Ongoing investigation into screening and referral rates should continue, with the goal of achieving universal screening of all children.
6. More research should be conducted to increase the evidence base for effectiveness of developmental surveillance and screening tools.
Read the Full Report here
The 2019 - 2020 COCWD Executive Committee includes Dennis Z. Kuo, MD, MHS, FAAP as Chairperson and Christopher Stille, MD, MPH, FAAP as a member!